Suppr超能文献

从蚕豆和莲子中提取的类黄酮糖苷对真核拓扑异构酶 I 和 II 的催化抑制作用。

Catalytic inhibition of eukaryotic topoisomerases I and II by flavonol glycosides extracted from Vicia faba and Lotus edulis.

机构信息

Department of Biochemistry and Biotechnology, University of Thessaly, Greece.

出版信息

J Nat Prod. 2011 Nov 28;74(11):2362-70. doi: 10.1021/np200292u. Epub 2011 Oct 20.

Abstract

Topoisomerases are essential enzymes involved in all processes of DNA metabolism, and their inhibitors have been identified as potential anticancer agents. The present study examined the effect of nine polyphenolic compounds derived from parts of two unique varieties of the Leguminosae, Vicia faba and Lotus edulis, on the activity of eukaryotic topoisomerases. We identified polyphenolic compounds that act as catalytic inhibitors of wheat germ topoisomerase I (IC50: 120-350 μM), human topoisomerase I (IC50: 110-260 μM), and human topoisomerase II (IC50: 240-600 μM) activities. Some compounds inhibited all enzymatic activities to a similar extent, while others exhibited specificity toward individual enzymes. The strongest catalytic inhibitor of all the examined enzymes was a kaempherol glycoside with an acetyl group linked to a sugar moiety. In addition, this compound inhibited the growth of human cancer cell lines MCF7, HeLa, and HepG2. The inhibition of topoisomerase I and II activities observed by the specific compounds possibly implies a role as potential agents in the prevention and therapy of cancer.

摘要

拓扑异构酶是参与所有 DNA 代谢过程的必需酶,其抑制剂已被鉴定为潜在的抗癌药物。本研究探讨了从豆科植物 Vicia faba 和 Lotus edulis 两个独特品种的部分提取的 9 种多酚化合物对真核拓扑异构酶活性的影响。我们鉴定出了多酚化合物,它们可作为小麦胚拓扑异构酶 I(IC50:120-350μM)、人拓扑异构酶 I(IC50:110-260μM)和人拓扑异构酶 II(IC50:240-600μM)的催化抑制剂。一些化合物对所有酶活性的抑制程度相似,而另一些化合物则对个别酶具有特异性。所有被检测酶中最强的催化抑制剂是一种带有乙酰基连接到糖部分的山柰酚糖苷。此外,该化合物还抑制了人癌细胞系 MCF7、Hela 和 HepG2 的生长。特异性化合物观察到的拓扑异构酶 I 和 II 活性的抑制可能意味着其作为预防和治疗癌症的潜在药物的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验